Steadtrust’s Abbott ABT Stock Holding History

Steadtrust’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,075	Closed	-$213K	–	133
2026 Q1	$213K	Buy	2,075 +3	+0.1%	+$339	0.12%	115
2025 Q4	$260K	Buy	2,072 +2	+0.1%	+$255	0.16%	106
2025 Q3	$277K	Buy	2,070 +119	+6%	+$15.6K	0.19%	97
2025 Q2	$265K	Buy	+1,951	New	+$257K	0.21%	95

Other funds holding ABT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Steadtrust's ABT Position: Q2 2026 in Review

Steadtrust sold out of Abbott (ABT) in Q2 2026, closing a stake of 2,075 shares — an estimated $213K sold.

Steadtrust first reported a position in ABT in Q2 2025 and held it in 4 quarters. The position peaked at $277K in Q3 2025. 2,954 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

Steadtrust reported no remaining Abbott position as of Q2 2026 after selling out during the quarter.
Steadtrust sold 2,075 Abbott shares in Q2 2026, an estimated $213K.
Steadtrust first reported a position in Abbott in Q2 2025 and held it in 4 quarters.
Steadtrust's Abbott position peaked at $277K in Q3 2025.
2,954 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Steadtrust's 13F filing for Q2 2026, filed 9 Jul 2026.